Related Experiment Videos
Flosequinan: a new vasodilator for the treatment of heart failure
1Department of Medicine (Clinical Cardiology), Royal Postgraduate Medical School, Hammersmith Hospital, London.
British Journal of Hospital Medicine
|May 5, 1993
Abstract:
The incidence and prevalence of congestive heart failure is increasing despite improvements in the management of myocardial infarction and hypertension. This trend is likely to continue as the proportion of elderly in the community increases. A new vasodilator, flosequinan, is currently under investigation and may improve prognosis.